Drugmakers, payers entered 100+ value-based contracts in 4 years More than 100 value-based contracts were reached between payers and drug manufacturers between 2014 and 2017, suggesting that these ...

To succeed in value-based relationships, physicians need timely access to comprehensive information about attributed patients, ideally augmented by predictive and prescriptive analytics to identify ...

Here’s how many hospitals and providers have inked value-based payment agreements with the five largest commercial U.S. insurers: 1. UnitedHealth Group had 1,100 hospitals and 110,000 physicians in ...

Value-based care was designed to deliver better outcomes, shared savings, and stronger payer-provider alignment. Yet in practice, contracts often stall under the weight of administrative complexity – ...

The goal in shifting from paying for volume to value-based care is simple: to align payers and healthcare providers around high-quality care that improves outcomes and lowers cost. Operationalizing ...

Just over three-quarters of health system and hospital C-suites say they plan to increase value-based care model participation within the next two years, up from the 57% who indicated similarly back ...

Shared savings programs are useful for nudging providers’ behavior toward value, but they aren’t a true payment model that can sustain a health system, according to one executive. “Shared savings ...

Sixty-four percent of healthcare organizations say they expect higher revenue this year from value-based care arrangements as compared to last year, finds a new report from Innovacer and the National ...

Value-based care has been slowly gaining traction in the U.S. Some Rhode Island providers are trying to transition their practices away from fee-for-service and toward value-based care The key ...

BELLEVUE, Wash.--(BUSINESS WIRE)--Edifecs, a Cotiviti business and pioneer in healthcare data interoperability, today announced the next generation of its Population Payment Management platform ...

Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported in Q3 CY2025, with sales up 32.5% year on year to $580.4 million. The company’s full-year revenue guidance of $2.08 billion at the ...